Literature DB >> 16116316

Fatty acid compositions of lipids in mesenteric adipose tissue and lymphoid cells in patients with and without Crohn's disease and their therapeutic implications.

Edward Westcott1, Alastair Windsor, Christine Mattacks, Caroline Pond, Stella Knight.   

Abstract

BACKGROUND: The physiological bases for roles of adipose tissue and fatty acids in the symptoms and dietary treatments of Crohn's disease (CD) are poorly understood. The hypothesis developed from experiments on rodents that perinodal adipocytes are specialized to provision adjacent lymphoid tissues was tested by comparing the composition of triacylglycerol and phospholipid fatty acids in homologous samples of mesenteric adipose tissue and lymph nodes from patients with or without CD.
METHODS: Mesenteric perinodal and other adipose tissue and lymph nodes were collected during elective surgery for CD and other conditions. Fatty acids were extracted, identified, and quantified by thin-layer and gas-liquid chromatography.
RESULTS: Perinodal adipose tissue contained more unsaturated fatty acids than other adipose tissue in controls, as reported for other mammals, but site-specific differences were absent in CD. Lipids from adipose and lymphoid tissues had more saturated fatty acids but fewer polyunsaturates in patients with CD than controls. In adipose tissue samples, depletion of n-3 polyunsaturates was greatest, but n-6 polyunsaturates, particularly arachidonic acid, were preferentially reduced in lymphoid cells. Ratios of n-6/n-3 polyunsaturates were higher in adipose tissue but lower in lymphoid cells in patients with CD than in controls.
CONCLUSIONS: Site-specific differences in fatty acid composition in normal human mesentery are consistent with local interactions between lymph node lymphoid cells and adjacent adipose tissue. These site-specific properties are absent in CD, causing anomalies in composition of lymphoid cell fatty acids, which may explain the efficacy of elemental diets containing oils rich in n-6 polyunsaturates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16116316     DOI: 10.1097/01.mib.0000179213.80778.9a

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  6 in total

Review 1.  Alternative macrophage activation and metabolism.

Authors:  Justin I Odegaard; Ajay Chawla
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

2.  Changes in adipocytes and dendritic cells in lymph node containing adipose depots during and after many weeks of mild inflammation.

Authors:  Dawn Sadler; Christine A Mattacks; Caroline M Pond
Journal:  J Anat       Date:  2005-12       Impact factor: 2.610

Review 3.  Exposure to the environmental endocrine disruptor TCDD and human reproductive dysfunction: Translating lessons from murine models.

Authors:  Kaylon L Bruner-Tran; Juan Gnecco; Tianbing Ding; Dana R Glore; Virginia Pensabene; Kevin G Osteen
Journal:  Reprod Toxicol       Date:  2016-07-14       Impact factor: 3.143

4.  Subcutaneous adipose tissue fatty acid desaturation in adults with and without rare adipose disorders.

Authors:  Jennifer K Yee; Susan A Phillips; Kambiz Allamehzadeh; Karen L Herbst
Journal:  Lipids Health Dis       Date:  2012-02-03       Impact factor: 3.876

5.  Lipidomic profiling in Crohn's disease: abnormalities in phosphatidylinositols, with preservation of ceramide, phosphatidylcholine and phosphatidylserine composition.

Authors:  Gavin W Sewell; Yusuf A Hannun; Xianlin Han; Grielof Koster; Jacek Bielawski; Victoria Goss; Philip J Smith; Farooq Z Rahman; Roser Vega; Stuart L Bloom; Ann P Walker; Anthony D Postle; Anthony W Segal
Journal:  Int J Biochem Cell Biol       Date:  2012-06-19       Impact factor: 5.085

Review 6.  The Role of the Lymphatic System in the Pathogenesis and Treatment of Inflammatory Bowel Disease.

Authors:  Dimitrios Nikolakis; Floris A E de Voogd; Maarten J Pruijt; Joep Grootjans; Marleen G van de Sande; Geert R D'Haens
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.